检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.

Brian I Rini,Thomas Powles,Michael B Atkins,Bernard Escudier,David F McDermott,Cristina Suarez,Sergio Bracarda,Walter M Stadler,Frede Donskov,Jae Lyun Lee,Robert Hawkins,Alain Ravaud,Boris Alekseev,Michael Staehler,Motohide Uemura,Ugo De Giorgi,Begoña Mellado,Camillo Porta,Bohuslav Melichar,Howard Gurney,Jens Bedke,Toni K Choueiri,Francis Parnis, Tarik Khaznadar,Alpa Thobhani,Shi Li,Elisabeth Piault-Louis, Gretchen Frantz,Mahrukh Huseni,Christina Schiff,Marjorie C Green,Robert J Motzer

The Lancet（2019）

引用 762|浏览48
暂无评分
摘要
F Hoffmann-La Roche Ltd and Genentech Inc.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要